EYRAplex: Mouse Cytokine/Chemokine (30‑plex)
EYRAplex: Mouse Cytokine/Chemokine (30‑plex)
Components
| Capture mAb | Capture bead mix: Mouse Cytokine/Chemokine (30-plex) |
| Detection mAb | Detection mAb mix: Mouse M5A |
| Standard | Standard mix K: EYRAplex, mouse |
| Fluorophore conjugate | Streptavidin-PE |
| Buffers/Solutions | Assay diluent: EYRAplex, mouse |
| Streptavidin-PE diluent | |
| Wash buffer concentrate | |
| Also provided | 96-well plate (black) |
| Adhesive plate covers | |
| Black plate lid |
In stock
Delivery 4-9 business days
Shipping $0
Precision
| Analyte | LOD (pg/ml) | LLOQ (pg/ml) | ULOQ (pg/ml) | Intra-assay CV(%) | Inter-assay CV(%) |
|---|---|---|---|---|---|
| CCL2 (MCP-1) | 2.0 | 4.9 | 5000 | 3 | 7 |
| CCL5 (RANTES) | 0.3 | 3.4 | 14000 | 4 | 7 |
| CCL11 (Eotaxin) | 0.3 | 5.4 | 5500 | 4 | 7 |
| CXCL1 (KC/GRO-α) | 1.3 | 9.8 | 10000 | 3 | 9 |
| CXCL2 (MIP-2) | 0.6 | 3.9 | 4000 | 4 | 10 |
| CXCL5 (LIX) | 1.4 | 14.6 | 15000 | 3 | 9 |
| CXCL9 (MIG) | 5.7 | 78.1 | 20000 | 4 | 5 |
| G-CSF | 1.2 | 3.2 | 13000 | 4 | 4 |
| GM-CSF | 2.0 | 9.8 | 10000 | 3 | 10 |
| IFN-γ | 0.2 | 2.7 | 11000 | 2 | 8 |
| IL-1α | 2.0 | 8.8 | 36000 | 3 | 6 |
| IL-1β | 2.0 | 6.1 | 25000 | 2 | 9 |
| IL-2 | 1.4 | 31.2 | 8000 | 3 | 11 |
| IL-3 | 0.6 | 3.7 | 15000 | 4 | 4 |
| IL-4 | 0.9 | 9.8 | 10000 | 3 | 8 |
| IL-5 | 0.2 | 2.3 | 9300 | 3 | 8 |
| IL-6 | 1.9 | 7.3 | 30000 | 3 | 8 |
| IL-7 | 6.0 | 31.2 | 8000 | 4 | 10 |
| IL-9 | 1.8 | 10.8 | 11000 | 4 | 5 |
| IL-10 | 0.9 | 6.1 | 25000 | 3 | 5 |
| IL-12 (p70) | 0.6 | 9.8 | 10000 | 4 | 7 |
| IL-12/-23 (p40) | 0.7 | 2.4 | 10000 | 3 | 6 |
| IL-13 | 0.8 | 3.7 | 15000 | 3 | 5 |
| IL-15 | 12.9 | 48.8 | 200000 | 3 | 7 |
| IL-17A | 0.3 | 2.4 | 10000 | 3 | 6 |
| IP-10 (CXCL10) | 0.9 | 6.8 | 7000 | 4 | 8 |
| LIF | 0.6 | 1.6 | 6400 | 2 | 5 |
| M-CSF | 1.0 | 6.8 | 28000 | 3 | 7 |
| TNF-α | 0.4 | 7.8 | 8000 | 3 | 7 |
| VEGF-A | 0.7 | 2.4 | 10000 | 3 | 6 |
Recovery
| Average recovery (%) in | ||||
|---|---|---|---|---|
| Analyte | Serum | |||
| CCL2 (MCP-1) | 121 | |||
| CCL5 (RANTES) | 62 | |||
| CCL11 (Eotaxin) | 71 | |||
| CXCL1 (KC/GRO-α) | 98 | |||
| CXCL2 (MIP-2) | 61 | |||
| CXCL5 (LIX) | * | |||
| CXCL9 (MIG) | 137 | |||
| G-CSF | 72 | |||
| GM-CSF | 89 | |||
| IFN-γ | 81 | |||
| IL-1α | 83 | |||
| IL-1β | 77 | |||
| IL-2 | 92 | |||
| IL-3 | 101 | |||
| IL-4 | * | |||
| IL-5 | 94 | |||
| IL-6 | 79 | |||
| IL-7 | 100 | |||
| IL-9 | 48 | |||
| IL-10 | 92 | |||
| IL-12 (p70) | 93 | |||
| IL-12/-23 (p40) | 97 | |||
| IL-13 | 34 | |||
| IL-15 | 114 | |||
| IL-17A | 98 | |||
| IP-10 (CXCL10) | 94 | |||
| LIF | 43 | |||
| M-CSF | * | |||
| TNF-α | 72 | |||
| VEGF-A | 74 | |||
Linearity
| Average recovery (%) in | ||||
|---|---|---|---|---|
| Analyte | Serum | |||
| CXCL5 (LIX) | 97 (dilution 1:32-1:256) | |||
| IL-4 | 90 (dilution 1:16-1:512) | |||
| M-CSF | 99 (dilution 1:8-1:128) | |||
CCL2 (MCP-1)
| Analyte description | Chemokine ligand 2 (CCL2), also called monocyte chemoattractant protein-1 (MCP-1) and JE, belongs to the CC chemokine family. CCL2 is secreted by a wide array of cells including monocytes, macrophages, dendritic cells, endothelial cells, astrocytes, and osteoblasts. In addition to its chemotactic properties, CCL2 is involved in processes of degranulation, upregulation of receptors, cell survival, and secretion of cytokines. Its presence in multiple tissues has been linked to various diseases such as Alzheimer's, diabetes, tuberculosis, osteoporosis, and cancer where CCL2 plays a role in tumor microenvironment. |
| Alternative names | C-C motif chemokine 2, Chemoattractant Protein 1, MCP-1, MCP1, HC11 |
| Cell type | Monocyte/MΦ |
GM-CSF
| Analyte description | Granulocyte macrophage-colony stimulating factor (GM-CSF) can be secreted by T cells, macrophages, endothelial cells, and fibroblasts. GM-CSF stimulates the survival and functional activities of myeloid, that is, monocytes, macrophages, DCs, neutrophils, and eosinophils. It also stimulates the differentiation and proliferation of hematological progenitors. |
| Alternative names | Granulocyte macrophage-colony stimulating factor, GM-CSF, CSF2 |
| Cell type | T cell |
IFN-γ
| Analyte description | Interferon-γ (IFN-γ) is the only type II interferon. This proinflammatory cytokine is secreted by activated T cells and NK cells. It activates macrophages and endothelial cells and regulates immune responses by affecting APCs, T cells, and B cells. Production of IFN-γ by helper T cells and cytotoxic T cells is a hallmark of the Th1-type phenotype. Thus, high-level production of IFN-γ is typically associated with effective host defense against intracellular pathogens. |
| Alternative names | Interferon-γ, Interferon-gamma, IFN-γ, IFN-gamma, IFN-g, IFNg |
| Cell type | T cell, Tc, Th1, NK cell |
IL-1α
| Analyte description | Interleukin 1α (IL-1α) is a pro-inflammatory cytokine primarily produced by monocytes, macrophages, and neutrophils. IL-1α induces acute phase responses such as fever, T cell, and macrophage activation. |
| Alternative names | Interleukin 1α, IL-1α, hematopoietin 1, Interleukin-1alpha, IL-1 alpha, IL1α, Interleukin-1 alpha |
| Cell type | Monocyte/MΦ, mDC |
IL-1β
| Analyte description | Interleukin 1ß (IL-1ß) is a proinflammatory cytokine and inducer of acute phase responses. IL-1ß is produced primarily by monocytes, macrophages, and dendritic cells after induction by microbes. |
| Alternative names | Interleukin-1ß, IL-1ß, IL-1F2, Interleukin-1beta, IL-1 beta, IL1b, Interleukin-1 beta |
| Cell type | Monocyte/MΦ, mDC |
IL-2
| Analyte description | Interleukin 2 (IL-2) is predominantly produced by activated T cells. IL-2 promotes the proliferation, differentiation, and survival of antigen-activated T cells and NK cells. After antigen stimulation, the cytokine also promotes the differentiation of T cells into effector and memory T cells. Therefore IL-2 plays an important role in the body's response to infection. IL-2 is also key to tolerance, as it promotes the differentiation of certain immature T cells into regulatory T cells in the thymus, ultimately preventing autoimmune diseases. |
| Alternative names | Interleukin-2, Interleukin 2, IL-2, IL2, T cell growth factor |
| Cell type | T cell, Th1, Th2, Th17, Tfh |
IL-3
| Analyte description | The cytokine interleukin 3 (IL-3) is mainly produced by activated T cells. IL-3 is also called multi-lineage-colony stimulating factor since it induces the growth and differentiation of many cells. IL-3 also activates mast cells, eosinophils, basophils, and macrophages. |
| Alternative names | Interleukin 3, IL-3, IL3, colony-stimulating factor, multi-CSF, mast cell growth factor, MULTI-CSF |
| Cell type | T cell, Th2 |
IL-4
| Analyte description | Interleukin 4 (IL-4) is produced primarily by Th2 cells, mast cells, eosinophils, and basophils. IL-4 was first identified to costimulate B cell growth; the cytokine is essential for B cell secretion of IgE and augments the production of IgG1 in vivo. In addition to regulating B cell growth and immunoglobulin secretion, IL-4 also affects T cells. In vitro, IL-4 promotes T cell growth and can induce cytolytic T cell activity. IL-4 also induces the differentiation of naive CD4 T cells into Th2 cells, which are characterized by their capacity to secrete the cytokines IL-4, IL-5, and IL-10 upon activation, while simultaneously inhibiting the generation of Th1 cells. |
| Alternative names | Interleukin 4, IL-4, IL4, BCGF-1, BSF-1 |
| Cell type | T cell, Th2, Treg |
IL-5
| Analyte description | Interleukin 5 (IL-5) is a pleiotropic cytokine primarily produced by T and NK cells. IL-5 specifically controls the survival, differentiation, and chemotaxis of eosinophils. But initially, IL-5 was characterized by its ability to support the growth and terminal differentiation of B cells. |
| Alternative names | Interleukin-5, IL-5, IL5, BCGF-2 |
| Cell type | T cell, Th2, NK cell |
IL-6
| Analyte description | Interleukin 6 (IL-6) is a pleiotropic cytokine produced by many different cell types and plays a role in a wide range of functions, such as immune responses, acute-phase reactions, and hematopoiesis. Among other things, it augments antibody production from activated B cells in vitro. |
| Alternative names | Interleukin 6, IL-6, IL6, IFB-B502, BSF-2, BCDF |
| Cell type | B cell, Monocyte/MΦ, mDC |
IL-10
| Analyte description | Interleukin 10 (IL-10) is a pleiotropic cytokine produced by activated T cells and monocytes. It can modulate the functions of immune responses in both a stimulatory and an inhibitory way. IL-10 is thereby involved in the regulation of immune reactions and inflammatory responses. |
| Alternative names | Interleukin-10, IL-10, IL10 |
| Cell type | T cell, Treg, Monocyte/MΦ, mDC |
IL-12 (p70)
| Analyte description | Interleukin 12 (IL-12) is, when biologically active, a heterodimer (p70) consisting of two covalently linked subunits, p35 and p40. The p40 subunit is shared with IL-23. IL-12 is produced by antigen-presenting cells, specifically dendritic cells, and macrophages. IL-12 is a proinflammatory cytokine that promotes Th1-type responses by inducing IFN-γ production and enhancing the proliferation and cytotoxicity of NK and T cells. |
| Alternative names | Interleukin 12, IL-12, IL12 |
| Cell type | Monocyte/MΦ, mDC |
IL-12/-23 (p40)
| Analyte description | Interleukin 12 (IL-12) is, when biologically active, a heterodimer (p70) consisting of two covalently linked subunits, p35 and p40. IL-12 is produced by antigen-presenting cells, specifically dendritic cells, and macrophages. IL-12 is a proinflammatory cytokine that promotes Th1-type responses by inducing IFN-γ production and enhancing the proliferation and cytotoxicity of NK and T cells. Interleukin-23 (IL-23) is a disulfide-linked heterodimer that consists of a unique p19 subunit and the p40 subunit of IL-12. IL-23 is a proinflammatory cytokine, which is produced by macrophages and dendritic cells upon infections with certain pathogens. The IL-23 receptor is expressed on Th17 cells, and IL-23 is responsible for Th17 expansion and stabilization. Since both IL-12 and IL-23 heterodimers comprise the p40 subunit, capture immunoassays based on antibodies to p40 will detect both cytokines. Such assays can also detect p40 monomers and dimers. |
| Alternative names | Interleukin 12, IL-12, IL12, IL12A, IL12B |
| Cell type | Monocyte/MΦ, mDC |
IL-13
| Analyte description | Interleukin 13 (IL-13) is produced by Th2-type cells, mast cells, and NK cells in response to activation. It regulates the secretion of IgE by B cells and the Th2-type cell development and suppresses inflammatory responses by regulation of macrophage function. |
| Alternative names | Interleukin 13, IL-13, IL13 |
| Cell type | T cell, Th2, Treg |
IL-17A
| Analyte description | Interleukin 17A (IL-17A) is a potent proinflammatory cytokine produced by activated Th17 (T helper 17) cells and certain cells belonging to the innate immune system. In mice, IL-17 has also been shown to be produced by activated CD8 T cells and γδ T cells. Th17 cells play an important role in autoimmune diseases and protection against bacteria and fungi. IL-17A acts on a broad range of cell types to induce the expression of cytokines, chemokines, and metalloproteinases. As a result, secretion of IL-17A promotes inflammatory responses, which leads to the recruitment of neutrophils, enhancement of antibody production, and activation of T cells. Increased expression of IL-17A is seen in autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. It is also associated with asthma, psoriasis, cancer, and transplant rejection. |
| Alternative names | Interleukin 17A, IL-17A, IL17A |
| Cell type | Th17 |
IP-10 (CXCL10)
| Analyte description | Interferon gamma-induced protein 10 (IP-10) secretion is induced by IFN-γ, TNF-α, and IL-1β. This proinflammatory cytokine is produced by monocytes, endothelial cells, and fibroblasts. The interferon gamma-induced protein 10 recruits lymphocytes to sites of infection and increases the expression of MHC class I molecules. In addition to chemotaxis, IP-10 is also involved in the differentiation and activation of peripheral immune cells, regulation of cell growth, apoptosis, and modulation of angiostatic effects. The binding of IP-10 (CXCL10) to the CXCR3 receptor causes the downstream activation of the phospholipase C-dependent pathway, an increase in intracellular calcium production, and actin reorganization. |
| Alternative names | Interferon gamma-induced protein 10, IP-10, C-X-C motif chemokine ligand 10, CXCL10, small-inducible cytokine B10 |
| Cell type | T cell, Monocyte/MΦ |
TNF-α
| Analyte description | Tumor necrosis factor (TNF), also known as TNF-α, is produced by many different cell types, e.g., monocytes, macrophages, T cells, and B cells. Among the many effects of TNF-α are protection against bacterial infection, cell growth modulation, immune system regulation, and involvement in septic shock. |
| Alternative names | Tumor necrosis factor-α, TNF-α, TNF-alpha, TNF-a, TNFa, Tumor necrosis factor-alpha, TNF |
| Cell type | T cell, Tc, Th1, Th2, Th17, Tfh, Monocyte/MΦ |
